Michigan has agreed to permanently stop enforcing its 2023 ban on so-called conversion therapy for minors, a major legal reversal with implications well beyond the state. The permanent order blocks House Bill 4616, which had exposed licensed counselors to discipline for certain talk-therapy practices involving minors experiencing gender dysphoria.
The decision follows a string of courtroom setbacks for the state, including a Sixth Circuit ruling and a U.S. Supreme Court decision on March 31 in Chiles v. Salazar. Together, those rulings reshaped the legal standard for state restrictions on counselor speech and increased pressure on similar laws across the country.
For investors, the immediate market impact is limited, but the case matters because it highlights rising regulatory risk in healthcare, behavioral health, insurance coverage, and professional liability. It also underscores how constitutional litigation can rapidly alter compliance frameworks for providers and state-regulated care models.
Key Facts
- Michigan signed a permanent federal court order on July 30, 2026, barring enforcement of House Bill 4616, a 2023 law targeting conversion therapy for minors.
- The law was signed in July 2023 and made Michigan the 22nd state to adopt such a ban.
- In late 2025, the Sixth Circuit reversed a lower-court ruling and became the first federal appeals court to block a statewide conversion therapy ban of this type.
- On March 31, 2026, the U.S. Supreme Court ruled 8-1 in Chiles v. Salazar that Colorado’s similar law must face strict First Amendment scrutiny.
- The Michigan case was brought by Catholic Charities of Jackson, Lenawee and Hillsdale Counties and therapist Emily McJones.
Michigan Conversion Therapy Ban
The Michigan conversion therapy ban was framed by state officials in 2023 as a measure to protect LGBTQ youth from harmful treatment practices. But the law’s wording became the central legal problem. It did not only target efforts to change sexual orientation; it also reached speech intended to influence behavior or gender expression, opening the door to constitutional challenges based on viewpoint discrimination.
That distinction proved decisive in court. The plaintiffs argued that Michigan was not simply regulating medical conduct, but restricting what licensed counselors could say in session. After an initial loss at the district court level in February 2025, they prevailed on appeal. The Sixth Circuit concluded that the state’s legal theory faced serious difficulty when applied to counseling consisting solely of spoken words.
The stakes extend beyond one state statute. Professional licensing rules often shape how care is delivered across behavioral health networks, nonprofit providers, and insurance-covered treatment channels. When courts classify such restrictions as speech regulation rather than ordinary medical oversight, states face a much higher bar to defend them. That changes the compliance environment for mental health providers, legal departments, and policymakers alike.
Michigan’s retreat shows that state limits on therapist speech now face a far steeper constitutional test, with consequences likely to ripple across healthcare regulation nationwide.
Why the legal standard changed
The Supreme Court’s March 31 ruling in Chiles v. Salazar accelerated Michigan’s reversal. By holding that Colorado’s nearly identical law must survive strict scrutiny, the Court signaled that speech by licensed professionals does not lose First Amendment protection simply because it occurs in a clinical setting. Strict scrutiny is the toughest standard in constitutional review and is difficult for governments to satisfy.
That ruling materially weakened Michigan’s position. The Supreme Court also cited the Sixth Circuit’s Michigan case, reinforcing the appellate reasoning that spoken counseling cannot easily be treated as unprotected conduct. Once that happened, the state’s room to preserve HB 4616 narrowed sharply, making a permanent injunction the most realistic legal outcome.
Implications for Investors
Publicly traded exposure to this issue is indirect, but investors should not dismiss it. Behavioral health providers, hospital systems with adolescent mental health programs, and insurers operating in multiple states may face a more fragmented regulatory map. Compliance protocols that were built around state bans may need revision, while litigation risk and policy uncertainty could raise legal and administrative costs.
For managed care organizations and healthcare services companies, the broader signal is that courts may more aggressively review state rules governing clinical speech, consent practices, and treatment pathways. That creates headline risk and operational complexity, especially for businesses active in pediatric care, telehealth counseling, and multi-state provider networks. Investors should watch whether other states revise, defend, or abandon comparable laws.
The case also has implications for nonprofit healthcare operators, malpractice insurers, and firms tied to professional licensing infrastructure. If legal standards continue shifting toward stricter constitutional review, organizations may need to invest more in policy monitoring, staff training, and litigation reserves. While this is not a sector-wide earnings event on its own, it fits a broader pattern in which court rulings can alter healthcare regulation faster than legislatures can respond.
Attention now turns to whether other states with similar bans will test their laws in court or move to rewrite them. For investors tracking healthcare regulation, the key watch points are further appellate decisions, state legislative responses, and any measurable effect on provider risk disclosures over the next several quarters.